The many vs. the few.
作者信息
Zallen Doris T
出版信息
Hastings Cent Rep. 2012 Sep-Oct;42(5):4-5; author reply 8-9. doi: 10.1002/hast.77.
DOI:10.1002/hast.77
PMID:22976402
Abstract
摘要
相似文献
1
The many vs. the few.多数与少数。
Hastings Cent Rep. 2012 Sep-Oct;42(5):4-5; author reply 8-9. doi: 10.1002/hast.77.
2
The many vs. the few.
Hastings Cent Rep. 2012 Sep-Oct;42(5):6-7; author reply 8-9.
3
The many vs. the few.
Hastings Cent Rep. 2012 Sep-Oct;42(5):5-6; author reply 8-9.
4
The many vs. the few.
Hastings Cent Rep. 2012 Sep-Oct;42(5):7; author reply 8-9.
5
The many vs. the few.
Hastings Cent Rep. 2012 Sep-Oct;42(5):7-8; author reply 8-9.
6
Two dreams.
Hastings Cent Rep. 2012 Jan-Feb;42(1):2. doi: 10.1002/hast.2.
7
How should we model rare disease allocation decisions?
Hastings Cent Rep. 2012 Jan-Feb;42(1):3. doi: 10.1002/hast.3.
8
Which orphans will find a home? The rule of rescue in resource allocation for rare diseases.哪些孤儿能找到归宿？罕见病资源分配中的救援原则。
Hastings Cent Rep. 2012 Jan-Feb;42(1):27-34. doi: 10.1002/hast.12.
9
Rationing of drugs for rare diseases.罕见病药物的配给
Pharmacoeconomics. 2006;24(4):315-6. doi: 10.2165/00019053-200624040-00001.
10
Rare diseases and effective treatments: are we delivering?罕见病与有效治疗：我们做到了吗？
Lancet. 2015 Feb 28;385(9970):750-2. doi: 10.1016/S0140-6736(15)60297-5.
引用本文的文献
1
A systematic review of moral reasons on orphan drug reimbursement.孤儿药补偿的道德理由系统评价。
Orphanet J Rare Dis. 2021 Jun 30;16(1):292. doi: 10.1186/s13023-021-01925-y.
Zotero 插件